Six Years, One Forged Prescription: Ruti Aga's Defence Became Her Sentence

The clinic printed on the prescription never existed. The person who wrote it was not a doctor — it was a family member with no medical registration, who explained under questioning that he had used "an old prescription pad from a former workplace." That clinic, whose stamp sat on the paper, came forward and disowned all of it: not our pad, not our stamp, not our man. In the Athletics Integrity Unit's statement on Thursday, that single sheet of paper turned out to be the whole case.

Six years for Ruti Aga. Two years for the presence of methylprednisolone, four years for fabricating the prescription. The clock runs from 10 September, the day her provisional suspension began. I count minutes the way others count losses: slowly, then all at once. Roughly 2,190 days. The Ethiopian marathoner is 32; she will be 38 when the count ends.

Her record was never ordinary. She won the 2026 Tokyo Marathon. She was second in Berlin in 2026 in about 2:18:34, among the fastest women's marathoners of that stretch. Three second places at World Marathon Majors. The kind of CV an agent frames and hangs on a wall.

Then a half marathon in China in March. She won it — and the time is not in the public record, so any judgement of the performance would be invention. The sample was collected there and returned methylprednisolone. The defence was straightforward: a knee injury, and the medication used to treat it. The investigation then produced the prescription, and the case changed shape.

Start with the correction that reframes the whole story. It was reported as a "prohibited steroid." Methylprednisolone is a glucocorticoid — WADA Prohibited List class S9 — and it is prohibited in-competition only, by injection, oral or rectal route. Anabolic steroids sit in class S1 and are banned at all times. That distinction is not semantic; it is legal.

Why it matters: in road racing the in-competition testing window opens at 23:59 the night before the race. A therapeutic injection into the knee days earlier, out of competition, is entirely lawful. The same injection still present in the body on race day is a violation. The offence here was never "taking a steroid"; it was route and timing — and route and timing were supposed to be explained by a document that did not exist.

There is a sharp irony in that. I walked through empty Signal Iduna Park once and heard the architecture breathe — some things make their loudest statement through absence. The clinic that supposedly issued the prescription was the loudest absence in this file. A credible medical record plus correct washout timing and this case likely never begins. Intra-articular injections for knee synovitis are standard sports medicine for distance runners; that plausibility is the strength of her story and also its trap. She could have had all of it. What she had was a forged prescription — and a fabricated document proves exactly one thing to any panel: intent to conceal.

The six-year arithmetic reads plainly. Two years: presence, without proven intent. Four years: the Code's standard tampering sanction. The 2+4 that becomes 6 tells us the panel rejected the no-significant-fault mitigation that would normally have reduced the presence charge. And backdating to 10 September is procedure, not mercy — provisional suspension time counts against the ban, so the athlete gains nothing in real terms.

Underneath sits a fact that belongs to a system, not an individual. The "doctor" was family. No credentialed team physician, no TUE application, no lawful record of the medication. When a knee swells and a start-money cheque is on the table, a glucocorticoid is the cheapest, most available tool — and the medical structure around it is informal. The prescription is a symptom of that gap, not its cause.

Then the economic layer: China's label races have long been a lucrative, low-risk income tier for East African marathoners between Majors. The appearance-fee economy and the AIU's testing economy are now colliding in the same races.

The easy move is to file this under "another doper caught." That move fails twice. Once on pharmacology: the substance found has no proven endurance benefit. Once on intent: the file does not describe a healthy athlete buying an edge; it describes an injured 32-year-old trusting the wrong piece of paper. The record book will remember a cheat. The document says she was an injured marathoner with no proper doctor.

None of that should soften the sanction. Four years for tampering is not disproportionate; it rests on statements made in an investigative interview, not on a sheet of paper alone. Write the asterisk, not the accusation. Note also that no Ethiopian federation statement surfaced — I learned at Signal Iduna that silence can be a form of attendance, but here it is only absence.

Still, one question hangs. A six-year ban for a substance with no proven endurance benefit will be cited two ways: as evidence of AIU rigour, and as evidence of disproportionate enforcement against African road runners. Both readings will be used; the queue of cases ahead will decide which holds. One thing is close to certain — her March result and prize money will almost certainly be voided, while the 2026 Tokyo title does not fall automatically, because this sanction establishes no earlier use.

A return at 38, the 2028 Olympic cycle gone, and an Ethiopian depth in which a 2:18 performer is not automatically selected. The career did not end on a number. It ended on a piece of paper.

The next time a 24-year-old's knee swells in Iten or Bekoji, the question will not be who wrote her prescription. It will be whether there was anyone there to write it at all.